Crystal structure of the human glucose transporter GLUT1
The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
The glucose transporter GLUT1 catalyses facilitative diffusion of glucose into erythrocytes and is responsible for glucose supply to the brain and other organs. Dysfunctional mutations may lead to GLUT1 deficiency syndrome, whereas overexpression of GLUT1 is a prognostic indicator for cancer. Despite decades of investigation, the structure of GLUT1 remains unknown. Here we report the crystal structure of human GLUT1 at 3.2 Å resolution. The full-length protein, which has a canonical major facilitator superfamily fold, is captured in an inward-open conformation. This structure allows accurate mapping and potential mechanistic interpretation of disease-associated mutations in GLUT1. Structure-based analysis of these mutations provides an insight into the alternating access mechanism of GLUT1 and other members of the sugar porter subfamily. Structural comparison of the uniporter GLUT1 with its bacterial homologue XylE, a proton-coupled xylose symporter, allows examination of the transport mechanisms of both passive facilitators and active transporters.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Briefly, the U-shaped intracellular helical bundle of GLUT1 is formed by three helixes and functions as a latch to secure GLUT1 in the outward open conformation making the sugar binding site accessible extracellularly (141).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [141]
In the citing paper
“GLUT1 has a single binding site that can be accessed by glucose (and other hexoses) from either side of the luminal and/or abluminal endothelial membrane extracellularly or intracellularly (141).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [141]
In the citing paper
“GLUT1 is expressed in endothelial cells, but not in neurons (141, 649).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [141]
In the citing paper
“After binding to the extracellular binding site, glucose enters GLUT1, which leads to a conformational change causing extracellular transmembrane domains 1, 4, and 7 to function as a latch to secure the inward open conformation of GLUT1 enabling release of glucose intracellularly (141).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [141]
In the citing paper
“Since glucose concentration is lower in the brain interstitial fluid (ISF) compared with plasma, GLUT1 favors blood-to-brain transport of circulating glucose (141, 390, 649).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [141]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
The PyMOL Molecular Graphics System
DeLano, W. L. (2002) · Medical Entomology and Zoology · Cited by 18,147
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
(1978) · Biochemical Education · doi:10.1016/0307-4412(78)90049-3 · Cited by 5,046
PHENIX : building new software for automated crystallographic structure determination
Adams, P. D., Grosse-Kunstleve, R. W., Hung, L.-W., Ioerger, T. R., McCoy, A. J., Moriarty, N. W., Read, R. J., Sacchettini, J. C., Sauter, N. K., & Terwilliger, T. C. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902016657 · Cited by 4,361
Pao, S. S., Paulsen, I. T., & Saier, M. H. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.1.1-34.1998 · Cited by 2,297
Sequence and Structure of a Human Glucose Transporter
Mueckler, M., Caruso, C., Baldwin, S. A., Panico, M., Blench, I., Morris, H. R., Allard, W. J., Lienhard, G. E., & Lodish, H. F. (1985) · Science · doi:10.1126/science.3839598 · Cited by 1,547
Simple Allosteric Model for Membrane Pumps
JARDETZKY, O. (1966) · Nature · doi:10.1038/211969a0 · Cited by 1,291
Research works printed but not linked: 1
- Mitchell, P. David Keilin’s respiratory chain concept and its chemiosmotic consequences. In Nobel Lectures, Chemistry 1971–1980 (ed. Forsén, S. ) (World Scientific Publishing Co., 1978)
Cited by
Items 101–200 of 806
Yan, N. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.07.009 · Cited by 101
Self-citationLipid Accumulation Mechanisms in Auto- and Heterotrophic Microalgae
Chen, H., & Jiang, J. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b03495 · Cited by 92
The Progress and Development of GLUT1 Inhibitors Targeting Cancer Energy Metabolism
Meng, Y., Xu, X. J., Luan, H., Li, L., Dai, W., Li, Z., & Bian, J. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0052 · Cited by 89
Nji, E., Chatzikyriakidou, Y., Landreh, M., & Drew, D. (2018) · Nature Communications · doi:10.1038/s41467-018-06702-3 · Cited by 81
Wang, L., Shi, Y., Jiang, J., Li, C., Zhang, H., Zhang, X., Jiang, T., Wang, L., Wang, Y., & Feng, L. (2022) · Small · doi:10.1002/smll.202203678 · Cited by 71
Quek, D. Q. Y., Nguyen, L. N., Fan, H., & Silver, D. L. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.721035 · Cited by 79
Structural basis of ion transport and inhibition in ferroportin
Pan, Y., Ren, Z., Gao, S., Shen, J., Wang, L., Xu, Z., Yu, Y., Bachina, P., Zhang, H., Fan, X., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19458-6 · Cited by 81
Self-citationOliveira, H., Fernandes, I., Brás, N. F., Faria, A., de Freitas, V. A. P., Calhau, C., & Mateus, N. F. D. C. B. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b00412 · Cited by 81
Structural comparison of GLUT1 to GLUT3 reveal transport regulation mechanism in sugar porter family
Custódio, T. F., Paulsen, P. A., Frain, K. M., & Pedersen, B. P. (2021) · Life Science Alliance · doi:10.26508/lsa.202000858 · Cited by 71
Ion and lipid orchestration of secondary active transport
Drew, D., & Boudker, O. (2024) · Nature · doi:10.1038/s41586-024-07062-3 · Cited by 84
“40,41), no ionizable groups coordinate the substrate 40 , and the proton carrier aspartate (D27) in transmembrane helix 1 (TM1) is located 10 Å from the binding site 31 .”
Wang, X., Ding, B., Liu, W., Qi, L., Li, J., Zheng, X., Song, Y., Li, Q., Wu, J., Zhang, M., et al. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c03478 · Cited by 83
Self-citationDiverse Roles of Protein Palmitoylation in Cancer Progression, Immunity, Stemness, and Beyond
Li, M., Zhang, L., & Chen, C.-W. D. (2023) · Cells · doi:10.3390/cells12182209 · Cited by 83
“Astrocyte elevated gene-1 (AEG-1) is an oncogene that is over-expressed in a wide variety of cancers [142–145].”
BackgroundHayashi, M. K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041177 · Cited by 78
“Among human MFS transporters, crystal structures are available for human GLUTs (glucose transporters; SLC2A), in both outward [65] and inward-facing [66] conformations showing that MFS transporters also transport substrates using an alternating access mechanism.”
BackgroundHuman Mutations in SLC2A9 (Glut9) Affect Transport Capacity for Urate
Ruiz, A., Gautschi, I., Schild, L., & Bonny, O. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00476 · Cited by 80
“In order to better localize the precise position of the mutants, we designed a homology 3D model of Glut9 based on the human Glut1 crystal recently published (Deng et al., 2014) (Figure 11).”
BackgroundMethodInfluentialMapping the multiscale structure of biological systems
Schaffer, L. V., & Ideker, T. (2021) · Cell Systems · doi:10.1016/j.cels.2021.05.012 · Cited by 75
Lee, T., Kim, I., Cheong, D. Y., Roh, S., Jung, H. G., Lee, S. W., Kim, H. S., Yoon, D. S., Hong, Y., & Lee, G. (2021) · Analytica Chimica Acta · doi:10.1016/j.aca.2021.338387 · Cited by 76
Membrane protein production and formulation for drug discovery
Gulezian, E., Crivello, C., Bednenko, J., Zafra, C., Zhang, Y., Colussi, P. A., & Hussain, S. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.05.006 · Cited by 80
N-linked Glycosylation of human SLC1A5 (ASCT2) transporter is critical for trafficking to membrane
Console, L., Scalise, M., Tarmakova, Z., Coe, I. R., & Indiveri, C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.03.017 · Cited by 84
Molecular Dynamics Simulations of the Human Glucose Transporter GLUT1
Park, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125361 · Cited by 80
“Thereby its functional role has been implied to stabilize the outward-facing conformation[18].”
BackgroundInfluentialThe molecular basis for sugar import in malaria parasites
Qureshi, A. A., Suades, A., Matsuoka, R., Brock, J., McComas, S. E., Nji, E., Orellana, L., Claesson, M., Delemotte, L., & Drew, D. (2020) · Nature · doi:10.1038/s41586-020-1963-z · Cited by 79
Kou, L., Sun, R., Jiang, X., Lin, X., Huang, H., Bao, S., Zhang, Y., Li, C., Chen, R., & Yao, Q. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c03564 · Cited by 75
Attacking the supply wagons to starve cancer cells to death
Selwan, E. M., Finicle, B. T., Kim, S. M., & Edinger, A. L. (2016) · FEBS Letters · doi:10.1002/1873-3468.12121 · Cited by 69
Tucker, D. F., Sullivan, J. T., Mattia, K.-A., Fisher, C. R., Barnes, T., Mabila, M. N., Wilf, R., Sulli, C., Pitts, M., Payne, R. J., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1716788115 · Cited by 76
“Glucose transporters undergo large ligand-induced conformational changes during their transport cycle and so can exist in several distinct states (11, 31, 34, 35).”
BackgroundInfluentialGlucose transporters: cellular links to hyperglycemia in insulin resistance and diabetes
Stringer, D. M., Zahradka, P. C., & Taylor, C. G. (2015) · Nutrition Reviews · doi:10.1093/nutrit/nuu012 · Cited by 83
“” Hydropathy and X-ray crystallography analysis of GLUT1, the first identified GLUT transporter, reveal a protein structure that contains 12 transmembrane a-helices that combine to form a central aqueous membrane channel for substrate transport.(17,18) This 12-transmembrane a-helical structure is characteristic of all…”
BackgroundEmerging role of N-myc downstream-regulated gene 2 (NDRG2) in cancer
Hu, W., Fan, C., Jiang, P., Ma, Z., Yan, X., Di, S., Jiang, S., Li, T. X., Cheng, Y., & Yang, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.6228 · Cited by 73
An Overview of Cell-Based Assay Platforms for the Solute Carrier Family of Transporters
Dvorak, V., Wiedmer, T., Ingles-Prieto, A., Altermatt, P., Batoulis, H., Bärenz, F., Bender, E., Digles, D., Dürrenberger, F., Heitman, L. H., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.722889 · Cited by 67
“, 2019)) families adopt a LeuT fold, while members of SLC2 (SLC2A1/GLUT1 (Deng et al., 2014)) and SLC16 (SLC16A7/MCT2 (Zhang B.”
BackgroundAnticancer agents interacting with membrane glucose transporters
Granchi, C., Fortunato, S., & Minutolo, F. (2016) · MedChemComm · doi:10.1039/c6md00287k · Cited by 72
Irudayanathan, F. J., Wang, N., Wang, X., & Nangia, S. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13378 · Cited by 76
Mechanism of high affinity inhibition of the human urate transporter URAT1
Tan, P. K., Ostertag, T. M., & Miner, J. N. (2016) · Scientific Reports · doi:10.1038/srep34995 · Cited by 78
Structural Basis for Blocking Sugar Uptake into the Malaria Parasite Plasmodium falciparum
Jiang, X. J., Yuan, Y., Huang, J., Zhang, S., Luo, S., Wang, N., Pu, D.-B., Zhao, N., Tang, Q., Hirata, K., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.015 · Cited by 75
Self-citationThompson, A. M. G., Ursu, O., Babkin, P., Iancu, C. V., Whang, A., Oprea, T. I., & Choe, J. (2016) · Scientific Reports · doi:10.1038/srep24240 · Cited by 73
“Consistent with this mechanism, available crystal structures of sugar porters capture the inward-facing (GlcP Se21 , human GLUT1 22 and bovine GLUT5 23 ; PDB IDs 4LDS, 4PYP and 4BY9, respectively), outward-occluded (XylE 28 and human GLUT3 29 ; PDB IDs 4GBY and 4ZWB, respectively) and outward-open…”
Application of glycosylation in targeted drug delivery
Chen, F., & Huang, G. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111612 · Cited by 70
A “Valve‐Closing” Starvation Strategy for Amplification of Tumor‐Specific Chemotherapy
Li, X., Jiang, C., Wang, Q., Yang, S., Cao, Y., Hao, J., Niu, D., Chen, Y., Han, B., Jia, X., et al. (2022) · Advanced Science · doi:10.1002/advs.202104671 · Cited by 73
Transport and inhibition mechanisms of human VMAT2
Wu, D., Chen, Q., Yu, Z., Huang, B., Zhao, J., Wang, Y., Su, J., Zhou, F., Yan, R., Li, N., et al. (2023) · Nature · doi:10.1038/s41586-023-06926-4 · Cited by 68
“These pseudo-symmetric features are consistently observed in other MFS transporters 35,36 .”
Sloothaak, J., Odoni, D. I., de Graaff, L. H., dos Santos, V. A. P. M., Schaap, P. J., & Tamayo‐Ramos, J. A. (2015) · Biotechnology for Biofuels · doi:10.1186/s13068-015-0317-9 · Cited by 72
“The typical structure of known glucose transporters comprises 12 transmembrane helix domains divided into 2 groups of 6 helixes [39, 40], and the HMMgluT was computed from a structure-based multiple sequence alignment incorporating transmembrane helix predictions, rather than using an alignment algorithm based on the…”
MethodIn silico pharmacology: Drug membrane partitioning and crossing
Meo, F. D., Fabre, G., Berka, K., Ossman, T., Chantemargue, B., Paloncýová, M., Marquet, P., Otyepka, M., & Trouillas, P. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.06.030 · Cited by 71
GLUT1 and GLUT3 involvement in anthocyanin gastric transport- Nanobased targeted approach
Oliveira, H., Roma‐Rodrigues, C., Santos, A. I., Veigas, B., Brás, N. F., Faria, A., Calhau, C., de Freitas, V. A. P., Baptista, P. V., Mateus, N. F. D. C. B., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-37283-2 · Cited by 70
Wang, C., Bao, X., Li, Y., Jiao, C., Hou, J., Zhang, Q., Zhang, W., Liu, W., & Shen, Y. (2015) · Data in Brief · doi:10.1016/j.dib.2015.05.005 · Cited by 68
Mammalian Glucose Transporter Activity Is Dependent upon Anionic and Conical Phospholipids
Hresko, R. C., Kraft, T. E., Quigley, A., Carpenter, E. P., & Hruz, P. W. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.730168 · Cited by 67
LncRNA GAL promotes colorectal cancer liver metastasis through stabilizing GLUT1
Li, B., Kang, H., Xiao, Y., Du, Y., Xiao, Y., Song, G., Zhang, Y., Guo, Y., Yang, F., He, F., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02230-z · Cited by 69
“Since the crystal structure of GLUT1 was reported [7], GLUT1 is considered a therapeutic target for cancer therapy (to starve cancer cells) [3].”
BackgroundNanoparticle-Based Targeted Therapeutics in Head-And-Neck Cancer
Wu, T.-T., & Zhou, S.-H. (2015) · International Journal of Medical Sciences · doi:10.7150/ijms.10083 · Cited by 64
“This major breakthrough serves as a basis for understanding the functional mechanism of Glut-1 and for the development of potential targeted therapeutic agents [46].”
BackgroundCooperative transport mechanism of human monocarboxylate transporter 2
Zhang, B., Jin, Q., Xu, L., Li, N., Meng, Y., Chang, S., Zheng, X., Wang, J., Chen, Y., Neculai, D., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16334-1 · Cited by 72
Mishra, R. K., Wei, C., Hresko, R. C., Bajpai, R., Heitmeier, M. R., Matulis, S. M., Nooka, A. K., Rosen, S. T., Hruz, P. W., Schiltz, G. E., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.628826 · Cited by 67
Medrano-Soto, A., Moreno-Hagelsieb, G., McLaughlin, D., Ye, Z. S., Hendargo, K. J., & Saier, M. H. (2018) · PLOS ONE · doi:10.1371/journal.pone.0192851 · Cited by 57
Haptic-enabled collaborative learning in virtual reality for schools
Webb, M., Tracey, M., Harwin, W., Tokatlı, O., Hwang, F., Johnson, R., Barrett, N., & Jones, C. I. (2021) · Education and Information Technologies · doi:10.1007/s10639-021-10639-4 · Cited by 77
Bavnhøj, L., Paulsen, P. A., Flores‐Canales, J. C., Schiøtt, B., & Pedersen, B. P. (2021) · Nature Plants · doi:10.1038/s41477-021-00992-0 · Cited by 65
Roles of galectin-3 in metabolic disorders and tumor cell metabolism
Li, Y., Li, X., Yu, L., Wang, L., Shi, Z., & Guo, X. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.09.118 · Cited by 67
Richter, E. A., Bilan, P. J., & Klip, A. (2025) · Physiological Reviews · doi:10.1152/physrev.00033.2024 · Cited by 64
Structural and functional insights into Spns2-mediated transport of sphingosine-1-phosphate
Chen, H., Ahmed, S., Zhao, H., Elghobashi-Meinhardt, N., Dai, Y., Kim, J. H., McDonald, J. G., Li, X., & Lee, C.-H. (2023) · Cell · doi:10.1016/j.cell.2023.04.028 · Cited by 63
Yu, D.-M., Zhao, J., Lee, E. E., Kim, D., Mahapatra, R., Rose, E. K., Zhou, Z., Hosler, C., Kurdi, A., Choe, J., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci170706 · Cited by 66
Screening of candidate substrates and coupling ions of transporters by thermostability shift assays
Majd, H., King, M. S., Palmer, S. M., Smith, A. C., Elbourne, L. D., Paulsen, I. T., Sharples, D., Henderson, P. J., & Kunji, E. R. (2018) · eLife · doi:10.7554/elife.38821 · Cited by 65
“The structure of GalP has not been determined, but those of its mammalian homologs GLUT1 ( Deng et al., 2014 ), GLUT3 ( Deng et al., 2015 ), and GLUT5 ( Nomura et al., 2015 ) are available ( Figure 2a ).”
Jiao, Y., Yang, L., Wang, R., Song, G., Fu, J., Wang, J., Gao, N., & Wang, H. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16121611 · Cited by 63
Lameijer, L. N., Hopkins, S. L., Brevé, T. G., Askes, S. H. C., & Bonnet, S. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201603066 · Cited by 63
Wu, Y., Lu, Z., Li, Y., Yang, J., & Zhang, X. (2020) · Nanomaterials · doi:10.3390/nano10081441 · Cited by 61
Wright, N. J., & Lee, S.-Y. (2019) · Worldwide Protein Data Bank · doi:10.2210/pdb6ob6/pdb · Cited by 62
Poustforoosh, A., Nematollahi, M. H., Hashemipour, H., & Pardakhty, A. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.02.015 · Cited by 63
Shriwas, P., Roberts, D. A., Li, Y., Wang, L., Qian, Y., Bergmeier, S. C., Hines, J. V., Adhicary, S., Nielsen, C. M., & Chen, X. (2021) · Cancer & Metabolism · doi:10.1186/s40170-021-00248-7 · Cited by 68
Therapeutic Mechanisms of Herbal Medicines Against Insulin Resistance: A Review
Li, J., Bai, L., Wei, F., Zhao, J., Wang, D., Xiao, Y., Yan, W., & Wei, J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00661 · Cited by 64
Giacomini, K. M., Galetin, A., & Huang, S. M. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1224 · Cited by 61
“10 References: (1) Deng, D. et al. Crystal structure of the human glucose transporter GLUT1. Nature 510, 121-5 (2014). (2) Rusu, V. et al. Type 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct Mechanisms. Cell 170, 199-212 e20 (2017). (3) Zamek-Gliszczynski, M.J. et al. ITC recommendations for tra…”
InfluentialStephen, J., Salam, F., Lekshmi, M., Kumar, S. H., & Varela, M. F. (2023) · Antibiotics · doi:10.3390/antibiotics12020343 · Cited by 68
“A historical example of a model uniporter of the MFS is GLUT1 [43].”
BackgroundRoles of GLUT-1 and HK-II expression in the biological behavior of head and neck cancer
Yang, H., Zhong, J., Zhou, S., & Han, H.-M. (2019) · Oncotarget · doi:10.18632/oncotarget.24684 · Cited by 63
Liu, X., Yang, J.-W., Zeng, J., Chen, X., Gao, Y. P., Kui, X.-Y., Liu, X., Zhang, Y., Zhang, Y., & Pei, Z. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.853596 · Cited by 72
“Multiple projects have indicated that the overexpression of SLC2A1 is closely related to the progression and metastasis of a variety of cancers (Rudlowski et al., 2004; Pereira et al., 2013; Deng et al., 2014; Berlth et al., 2015; Avanzato et al., 2018).”
BackgroundGLUT1 and TUBB4 in Glioblastoma Could be Efficacious Targets
Guda, M. R., Labak, C. M., Omar, S. I., Asuthkar, S., Airala, S., Tuszyński, J. A., Tsung, A. J., & Velpula, K. K. (2019) · Cancers · doi:10.3390/cancers11091308 · Cited by 64
“The first was the 4PYP [21] structure and the second was a homology model of the entire protein based on the 5EQH [22] structure.”
BackgroundMethodMalik, A., Jamil, U., Butt, T. T., Waquar, S., Gan, S. H., Shafique, H., & Jafar, T. H. (2019) · Drug Design Development and Therapy · doi:10.2147/dddt.s176698 · Cited by 67
“Thr-30, Gln-161, Ile-164, Val-165, Ile-168, Gln-282, Gln-283, Ile287, Asn-288, Phe-291, Asn-317, Pro-380, Gly-384, Pro-385, Try-388, Phe389, Asn-411, and Asn-415 were observed as key binding sites for GLUT-4 based on literature.(48) The B-nonylglucoside ligand bound with GLUT1 and in the current study both ligands bou…”
BackgroundStructural basis for urate recognition and apigenin inhibition of human GLUT9
Shen, Z., Xu, L., Wu, T., Wang, H., Wang, Q., Ge, X., Kong, F., Huang, G., & Pan, X. (2024) · Nature Communications · doi:10.1038/s41467-024-49420-9 · Cited by 62
“Protein preparation:the structuresof GLUT9-UA and GLUT1(PDBcode: 4PYP) 33 were re fi ned and prepared in Schrödinger Maestro v13.”
InfluentialAvian and Mammalian Facilitative Glucose Transporters
Byers, M. S., Howard, C., & Wang, X. (2017) · Microarrays · doi:10.3390/microarrays6020007 · Cited by 69
“Microcephaly, childhood epilepsy [18,19], hypoglycorrhachia [20,21], cryohydrocytosis [22], choreathetosis [23], ataxia [22], migraines [24,25], spasticity, dyskinesia [26], indicator for cancer [27], thymic carcinoma [28].”
BackgroundDevelopment of Glucose Transporter (GLUT) Inhibitors
Reckzeh, E. S., & Waldmann, H. (2019) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201901353 · Cited by 63
Hou, Y., Hossain, G. S., Li, J., Shin, H., Liu, L., & Du, G. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-6757-0 · Cited by 57
Nanodisk-based glioma-targeted drug delivery enabled by a stable glycopeptide
Wang, H., Wang, X., Xie, C., Zhang, M., Ruan, H., Wang, S., Jiang, K., Wang, F., Zhan, C., Lu, W., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.06.006 · Cited by 59
A highly permselective electrochemical glucose sensor using red blood cell membrane
Kim, I., Kwon, D., Lee, D., Lee, J. H., Lee, J. H., Lee, G., & Yoon, D. S. (2017) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2017.12.002 · Cited by 56
“The RBCM exclusively facilitate the diffusion of glucose through the GLUT1 of RBCM; the inset box (bottom right) depicts the working model of GLUT1 with three different types of conformations (Deng et al. 2014).”
BackgroundHan, F., Oliveira, H., Brás, N. F., Fernandes, I., Cruz, L., de Freitas, V. A. P., & Mateus, N. F. D. C. B. (2020) · Food Chemistry · doi:10.1016/j.foodchem.2020.126398 · Cited by 56
Structure of, and functional insight into the GLUT family of membrane transporters
Cheeseman, C. I., & Long, W. (2015) · Cell Health and Cytoskeleton · doi:10.2147/chc.s60484 · Cited by 66
“13 It is a 509 amino acid protein that has 65.3%, 54.3%, and 57.5% identities with GLUT1, GLUT2, and GLUT3, respectively.”
InfluentialInhibitor Discovery for the Human GLUT1 from Homology Modeling and Virtual Screening
Ung, P. M.-U., Song, W., Cheng, L., Zhao, X., Hu, H., Chen, L., & Schlessinger, A. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00304 · Cited by 54
Pardridge, W. M. (2016) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2016.1230195 · Cited by 56
“three-dimensional structure of GLUT1 has been reported [56], and antibodies targeting GLUT1 for BBB drug delivery purposes would be directed against the extracellular gate domain of the transporter protein.”
BackgroundSchlessinger, A., Welch, M. A., van Vlijmen, H., Korzekwa, K., Swaan, P. W., & Matsson, P. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1174 · Cited by 56
Circular RNA: A novel potential biomarker for skin diseases
Wu, X., Xiao, Y., Ma, J., & Wang, A. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104841 · Cited by 57
Sun, R., Meng, X., Pu, Y., Sun, F., Man, Z., Zhang, J., Yin, L., & Pu, Y. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.11.005 · Cited by 55
Dong, H., Yang, X. D., Xie, J., Xiang, L., Li, Y., Ou, M., Chi, T., Liu, Z., Yu, S., Gao, Y., et al. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.11.014 · Cited by 53
Yang, X. D., Li, Y., Jiang, W., Ou, M., Chen, Y., Xu, Y., Wu, Q., Zheng, Q. L., Wu, F., Wang, L., et al. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12608 · Cited by 53
Mutant CTNNB1 and histological heterogeneity define metabolic subtypes of hepatoblastoma
Crippa, S., Ancey, P., Vázquez, J., Angelino, P., Rougemont, A., Guettier, C., Zoete, V., Delorenzi, M., Michielin, O. A., & Meylan, E. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201707814 · Cited by 54
Chemical biology probes of mammalian GLUT structure and function
Holman, G. D. (2018) · Biochemical Journal · doi:10.1042/bcj20170677 · Cited by 49
Structure and Function of Thyroid Hormone Plasma Membrane Transporters
Schweizer, U., Johannes, J., Bayer, D., & Braun, D. (2014) · European Thyroid Journal · doi:10.1159/000367858 · Cited by 49
Structures suggest a mechanism for energy coupling by a family of organic anion transporters
Leano, J. B., Batarni, S., Eriksen, J., Juge, N., Pak, J. E., Kimura‐Someya, T., Robles‐Colmenares, Y., Moriyama, Y., Stroud, R. M., & Edwards, R. H. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000260 · Cited by 52
“Abbreviations: Arg47, arginine-47; Asn141, asparagine-141; Asp46, aspartate-46; β-NG, βnonylglucoside; DDM, n-dodecyl-β-maltoside; DgoT, D-galactonate transporter; Fo-Fc, observed structure factor—calculated structure factor; Gln179, glutamine-179; GlpT, Glycerol-3phosphate transporter; Glut3, glucose transporter 3; H…”
BackgroundInfluentialGLUT1 participates in tamoxifen resistance in breast cancer cells through autophagy regulation
Sun, M., Zhao, S., Duan, Y., Ma, Y., Wang, Y., Ji, H., & Zhang, Q. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01893-3 · Cited by 53
“Glucose transporter 1 (GLUT1) belongs to the facilitative cell surface glucose transporter family, the members of which regulate glucose transport across the cell membrane (Deng et al. 2014).”
BackgroundShao, K., Zhang, Y. X., Ding, N., Huang, S., Wu, J., Li, J., Yang, C., Leng, Q., Ye, L., Lou, J., et al. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201400214 · Cited by 54
Self-citationToward a Molecular Basis of Cellular Nucleoside Transport in Humans
Wright, N. A., & Lee, S. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00644 · Cited by 52
Luo, J., Wang, H., Wang, L., Wang, G., Yao, Y., Xie, K., Li, X., Xu, L., Shen, Y., & Ren, B. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.04.022 · Cited by 54
Gu, M., Tan, M., Zhou, L., Sun, X., Lu, Q., Wang, M., Jiang, H., Liang, Y., Hou, Q., Xue, X., et al. (2022) · Kidney International · doi:10.1016/j.kint.2022.03.024 · Cited by 52
Assessing Glucose Uptake through the Yeast Hexose Transporter 1 (Hxt1)
Roy, A., Dement, A. D., Cho, K. H., & Kim, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121985 · Cited by 50
Luo, Q., Gong, P., Sun, M., Kou, L., Ganapathy, V., Jing, Y., He, Z., & Sun, J. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.10.031 · Cited by 50
“at one side of the membrane in a specific conformation, undergo a conformational change through the occluded state and then release the substrates on the other side in a different conformation [1].”
BackgroundTargeting pathogen metabolism without collateral damage to the host
Haanstra, J. R., Gerding, A., Dolga, A. M., Sorgdrager, F. J. H., Buist‐Homan, M., du Toit, F., Faber, K. N., Holzhütter, H., Szöőr, B., Matthews, K. R., et al. (2017) · Scientific Reports · doi:10.1038/srep40406 · Cited by 55
“We set out to test the model’s prediction that inhibition of glucose transport will affect T . brucei glycolysis without harming that of the erythrocytes, even if the inhibitor is not selective for the trypanosome transporter THT1 over the erythrocyte transporter GLUT1 25 .”
InfluentialGlycolysis Inhibition as a Strategy for Hepatocellular Carcinoma Treatment?
Alves, Â., Mamede, A. C., Alves, M. G., Oliveira, P. F., Rocha, S. M., Botelho, M. F., & Maia, C. J. (2018) · Current Cancer Drug Targets · doi:10.2174/1568009618666180430144441 · Cited by 50
Luo, P., Zhang, Q., Shen, S., An, Y., Yuan, L., Wong, Y., Huang, S., Huang, S., Huang, J., Cheng, G., et al. (2023) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2023.100874 · Cited by 86
“GLUT1 mediates the transmembrane transport of glucose in tumor cells [58,59] .”
BackgroundA Microdevice Platform Recapitulating Hypoxic Tumor Microenvironments
Ando, Y., Ta, H. P., Yen, D. P., Lee, S., Raola, S., & Shen, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-15583-3 · Cited by 50
Xiang, T., Jinkerson, R. E., Clowez, S., Tran, C., Krediet, C. J., Onishi, M., Cleves, P. A., Pringle, J. R., & Grossman, A. R. (2017) · PLANT PHYSIOLOGY · doi:10.1104/pp.17.01572 · Cited by 50
“6C, stars) as well as the sugar-transporter signature motifs D(N)RXGRR and PETK (Deng et al., 2014; Fig.”
BackgroundMfsd2a: A Physiologically Important Lysolipid Transporter in the Brain and Eye
Wong, B. H., & Silver, D. L. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-6082-8_14 · Cited by 56
Molecular basis for inhibiting human glucose transporters by exofacial inhibitors
Wang, N., Zhang, S., Yuan, Y., Xu, H., Defoßa, E., Matter, H., Besenius, M., Derdau, V., Dreyer, M., Halland, N., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30326-3 · Cited by 50
Self-citationMa, J., Wang, Q., Yang, X., Hao, W., Huang, Z., Zhang, J., Wang, X., & Wang, P. G. (2016) · Dalton Transactions · doi:10.1039/c6dt02207c · Cited by 48
The role of hypoxia in oral cancer and potentially malignant disorders: a review
Kujan, O., Shearston, K., & Farah, C. S. (2016) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12488 · Cited by 49
Understanding Conformational Dynamics of Complex Lipid Mixtures Relevant to Biology
Friedman, R., Khalid, S., Aponte-Santamaria, C. A., Arutyunova, E. I., Becker, M., Boyd, K. J., Christensen, M. H., Coimbra, J. T. S., Concilio, S., Daday, C., et al. (2018) · The Journal of Membrane Biology · doi:10.1007/s00232-018-0050-y · Cited by 52
Metadata
- Authors
- Deng, D., Xu, C., Sun, P., Wu, J., Yan, C., Hu, M., & Yan, N.
- Affiliations
- Center for Life Sciences (CN)
- Tsinghua University (CN)
- Corresponding author
- Yan, Nieng
- Venue
- Nature
- Published
- 2014-05-18
- Volume
- 510
- Issue
- 7503
- Pages
- 121-125
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1987612677
- Cited by
- 777
- References
- 62
- Citations by year
- 2026: 50 · 2025: 64 · 2024: 64 · 2023: 52 · 2022: 72 · 2021: 73 · 2020: 70 · 2019: 59 · 2018: 64 · 2017: 67 · 2016: 57 · 2015: 65 · 2014: 19
- FWCI
- 31.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- GLUT1, glucose transporters, crystal structure, major facilitator superfamily, inward-open conformation, GLUT1 deficiency syndrome, disease-associated mutations, alternating access mechanism, XylE, proton-coupled transport, anticancer drug targets
- MeSH terms
- Carbohydrate Metabolism, Inborn Errors, Humans, Ligands, Models, Biological, Models, Molecular, Monosaccharide Transport Proteins, Mutation, Structure-Activity Relationship, Protein Structure, Tertiary, Crystallography, X-Ray, Symporters, Escherichia coli Proteins, Glucose Transporter Type 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.